A disturbing situation has begun occurring in the medical community, and it has to do with the pharmaceutical supply chain management. In a number of cases, critical drugs that are expensive and essential for patients to survive conditions are running into short supply. Almost unheard of decades before, today certain drugs are now not available. The situation is putting affected patients are at risk and the cause seems to be about business.
Reasons
The reasons for drug shortages vary but some stand out. The most basic driver is profit. If a drug company is not making money off a particular product, it discontinues the production to lower operating costs, regardless of whether a small group of patients need that drug. On the flip-side, if a brand name pharmaceutical makes money, the same company may cut off its generic version, forcing buyers to purchase the more expensive brand name version.
In some cases doctors and clinics can sell directly the drugs provided to patients. This creates a mark-up scenario since patients can only get particular drugs from specific doctors providing a given treatment. Cancer treatment is one example that falls into this scenario.
Reasons
The reasons for drug shortages vary but some stand out. The most basic driver is profit. If a drug company is not making money off a particular product, it discontinues the production to lower operating costs, regardless of whether a small group of patients need that drug. On the flip-side, if a brand name pharmaceutical makes money, the same company may cut off its generic version, forcing buyers to purchase the more expensive brand name version.
In some cases doctors and clinics can sell directly the drugs provided to patients. This creates a mark-up scenario since patients can only get particular drugs from specific doctors providing a given treatment. Cancer treatment is one example that falls into this scenario.